Literature DB >> 20643851

A decade of Burkholderia cenocepacia virulence determinant research.

Slade A Loutet1, Miguel A Valvano.   

Abstract

The Burkholderia cepacia complex (Bcc) is a group of genetically related environmental bacteria that can cause chronic opportunistic infections in patients with cystic fibrosis (CF) and other underlying diseases. These infections are difficult to treat due to the inherent resistance of the bacteria to antibiotics. Bacteria can spread between CF patients through social contact and sometimes cause cepacia syndrome, a fatal pneumonia accompanied by septicemia. Burkholderia cenocepacia has been the focus of attention because initially it was the most common Bcc species isolated from patients with CF in North America and Europe. Today, B. cenocepacia, along with Burkholderia multivorans, is the most prevalent Bcc species in patients with CF. Given the progress that has been made in our understanding of B. cenocepacia over the past decade, we thought that it was an appropriate time to review our knowledge of the pathogenesis of B. cenocepacia, paying particular attention to the characterization of virulence determinants and the new tools that have been developed to study them. A common theme emerging from these studies is that B. cenocepacia establishes chronic infections in immunocompromised patients, which depend more on determinants mediating host niche adaptation than those involved directly in host cells and tissue damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643851      PMCID: PMC2950345          DOI: 10.1128/IAI.00212-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  175 in total

1.  A temperature-dependent switch from chaperone to protease in a widely conserved heat shock protein.

Authors:  C Spiess; A Beil; M Ehrmann
Journal:  Cell       Date:  1999-04-30       Impact factor: 41.582

2.  The Salmonella selC locus contains a pathogenicity island mediating intramacrophage survival.

Authors:  A B Blanc-Potard; E A Groisman
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

Review 3.  Census and consensus in bacterial ecosystems: the LuxR-LuxI family of quorum-sensing transcriptional regulators.

Authors:  C Fuqua; S C Winans; E P Greenberg
Journal:  Annu Rev Microbiol       Date:  1996       Impact factor: 15.500

4.  Regiospecificity of dioxygenation of di- to pentachlorobiphenyls and their degradation to chlorobenzoates by the bph-encoded catabolic pathway of Burkholderia sp. strain LB400.

Authors:  M Seeger; M Zielinski; K N Timmis; B Hofer
Journal:  Appl Environ Microbiol       Date:  1999-08       Impact factor: 4.792

5.  Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth.

Authors:  M Desai; T Bühler; P H Weller; M R Brown
Journal:  J Antimicrob Chemother       Date:  1998-08       Impact factor: 5.790

6.  Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.

Authors:  J Turner; Y Cho; N N Dinh; A J Waring; R I Lehrer
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

7.  Siderophore production by cystic fibrosis isolates of Burkholderia cepacia.

Authors:  P Darling; M Chan; A D Cox; P A Sokol
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

8.  Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

Authors:  P Vandamme; B Holmes; M Vancanneyt; T Coenye; B Hoste; R Coopman; H Revets; S Lauwers; M Gillis; K Kersters; J R Govan
Journal:  Int J Syst Bacteriol       Date:  1997-10

9.  Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting.

Authors:  E Mahenthiralingam; M E Campbell; D A Henry; D P Speert
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

10.  Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI.

Authors:  S Lewenza; B Conway; E P Greenberg; P A Sokol
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.490

View more
  61 in total

1.  The Burkholderia cenocepacia LysR-type transcriptional regulator ShvR influences expression of quorum-sensing, protease, type II secretion, and afc genes.

Authors:  Eoin P O'Grady; David T Nguyen; Laure Weisskopf; Leo Eberl; Pamela A Sokol
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

2.  Diversity of potential pathogenicity and biofilm formation among Burkholderia cepacia complex water, clinical, and agricultural isolates in China.

Authors:  Muhammad Ibrahim; Qiaomei Tang; Yu Shi; Abdulwareth Almoneafy; Yuan Fang; Liuhu Xu; Wen Li; Bin Li; Guan-Lin Xie
Journal:  World J Microbiol Biotechnol       Date:  2012-02-09       Impact factor: 3.312

3.  The Essential Genome of Burkholderia cenocepacia H111.

Authors:  Steven Higgins; Maria Sanchez-Contreras; Stefano Gualdi; Marta Pinto-Carbó; Aurélien Carlier; Leo Eberl
Journal:  J Bacteriol       Date:  2017-10-17       Impact factor: 3.490

4.  Depletion of the ubiquitin-binding adaptor molecule SQSTM1/p62 from macrophages harboring cftr ΔF508 mutation improves the delivery of Burkholderia cenocepacia to the autophagic machinery.

Authors:  Basant A Abdulrahman; Arwa Abu Khweek; Anwari Akhter; Kyle Caution; Mia Tazi; Hoda Hassan; Yucheng Zhang; Patrick D Rowland; Sankalp Malhotra; Famke Aeffner; Ian C Davis; Miguel A Valvano; Amal O Amer
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

5.  Burkholderia cenocepacia O polysaccharide chain contributes to caspase-1-dependent IL-1beta production in macrophages.

Authors:  Sheetal Kotrange; Benjamin Kopp; Anwari Akhter; Dalia Abdelaziz; Arwa Abu Khweek; Kyle Caution; Basant Abdulrahman; Mark D Wewers; Karen McCoy; Clay Marsh; Slade A Loutet; Ximena Ortega; Miguel A Valvano; Amal O Amer
Journal:  J Leukoc Biol       Date:  2010-12-22       Impact factor: 4.962

6.  Hopanoid production is required for low-pH tolerance, antimicrobial resistance, and motility in Burkholderia cenocepacia.

Authors:  Crystal L Schmerk; Mark A Bernards; Miguel A Valvano
Journal:  J Bacteriol       Date:  2011-09-30       Impact factor: 3.490

7.  Identification of Burkholderia cenocepacia strain H111 virulence factors using nonmammalian infection hosts.

Authors:  Stephan Schwager; Kirsty Agnoli; Manuela Köthe; Friederike Feldmann; Michael Givskov; Aurelien Carlier; Leo Eberl
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

8.  Use of Synthetic Hybrid Strains To Determine the Role of Replicon 3 in Virulence of the Burkholderia cepacia Complex.

Authors:  Kirsty Agnoli; Roman Freitag; Margarida C Gomes; Christian Jenul; Angela Suppiger; Olga Mannweiler; Carmen Frauenknecht; Daniel Janser; Annette C Vergunst; Leo Eberl
Journal:  Appl Environ Microbiol       Date:  2017-06-16       Impact factor: 4.792

9.  Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex.

Authors:  Saira Ahmad; Jean Tyrrell; William G Walton; Ashutosh Tripathy; Matthew R Redinbo; Robert Tarran
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

10.  First cases of Burkholderia cenocepacia IIIA neonatal sepsis in Central African Republic.

Authors:  Thierry Frank; Julita Gil-Cuesta; Jean Robert Mbecko; Hugues Sanke; Chantal Lakis; Anne Le Flèche-Matéos; Alain Berlioz-Arthaud
Journal:  Pan Afr Med J       Date:  2020-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.